Facebook  Twitter  Youtube  ISSUU  RSS  Email


Media Contacts

UK
Press Office
press@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police moneylaundering money laundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK These revelations add further pressure on the UK Government to address the problems highlighted by the #LuandaLeakshttps://t.co/I6knaAuzUP
12hreplyretweetfavorite
TransparencyUK Whilst the harm is felt most by the people of Angola, this is a transnational problem, with secrecy offered by coun… https://t.co/JfC9tVMbal
12hreplyretweetfavorite
TransparencyUK Our Anti-Bribery Guidance now includes summaries of anti #bribery legislation for… 🇧🇭 Bahrain 🇨🇱 Chile 🇨🇴 Colombia… https://t.co/tX0L6KtHiI

Stay Informed

Sign up for updates on Transparency International UK's work,corruption news from around the world and fundraising and events updates.

Recent Blog Posts

Search Blog

Guest blogger Shalni Arora looks at corruption’s impact in the healthcare sector, and reflects on what it means for both the achievement of the new development goals as well as universal health coverage.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

While the ‘evergreening’ and ‘forced switching’ of pharmaceutical patents are legal practices, they act to reduce access to medicines for many and often those most vulnerable and so could be considered unethical or morally corrupt practices. Søren Holm, Professor of Bioethics at the University of Manchester, discusses the pharmaceutical patent game and its impacts.

Our response to today’s news that UK pharmaceuticals firm GlaxoSmithKline has been fined £297m for bribery by Chinese authorities. 

With a worth of US$6.5 trillion, the global healthcare industry is especially vulnerable to corruption. Although the problem is particularly acute in countries where corruption is endemic, no country is immune.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of